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Abstract
Diarrhea is an important cause of morbidity and mortality amongst infants of low
socio-economic levels in developing countries and in travelers who visit such areas.
Enterotoxigenic E. coli strains express two sets of virulence-associated factors:
enterotoxins (heat-stable toxins or heat-labile toxins) and colonization factors.
Studies have shown that breast-feeding protects infants against infectious diseases,
such as diarrhea, as it presents a great variety of immunological components. The
aim of this study was to analyze the reactivity of immunoglobulin A from human
colostrum to colonization factor antigens I and II. The colostrum ability in
preventing enterotoxigenic E. coli adhesion to Caco-2 cells was also evaluated.
Colostrum samples were collected from 32 healthy women, and a human colostrum
pool was prepared. Enterotoxigenic E. coli strains expressing colonization factor
antigens I and II were utilized. The colostrum pool and individual samples showed
variable antienterotoxigenic E. coli immunoglobulin A titers, that were reactive with
colonization factor antigen I and CS1/CS3 (colonization factor antigen II). The
human colostrum pool and individual samples inhibited enterotoxigenic E. coli
colonization factor antigen I and II adhesion to Caco-2 cells, at variable levels, and
this ability was a result of immunoglobulin A antibodies reactive to these coloniza-
tion factors. The immunoglobulin A-depleted pool lost this inhibitory ability. As
bacterial adhesion is the initial mechanism of enterotoxigenic E. coli infection,
breast-feeding could protect the offspring against diarrhea caused by this agent.
Introduction
Diarrhea continues to be an important cause of morbidity
and mortality amongst infants of low socio-economic levels
in developing countries. Of the several bacterial agents
associated with this syndrome, enterotoxigenic Escherichia
coli (ETEC) is one of the most common causes of acute
diarrhea in children less than 5 years of age and in travelers
who visit such areas (Black et al., 1981, 2003). In order to
cause the disease, ETEC strains must express two sets of
virulence-associated factors: enterotoxins [heat-stable toxins
(ST) or heat-labile toxins (LT)] and colonization factors
(CFs), consisting of a set of diverse fimbrial or afimbrial
adhesins conferring host and tissue specificity (Nataro &
Kaper, 1998). Of the great variety of CFs described so far,
colonization factor antigen I (CFA/I), colonization factor
antigen II (CFA/II) and colonization factor antigen IV
(CFA/IV) are the best characterized on both a structural
and genetic basis. CFA/I is composed of a single antigen,
whereas CFA/II comprises a family of coli surface (CS)
antigens (CS1, CS2 and CS3), the latter of which has been
found alone or associated with CS1 or CS2 (Smyth, 1982;
Wolf, 1997; Oyofo et al., 2001). Primary experiments to test
the role of these antigens in colonization have been carried
out on animal models, but in vitro studies using different
cell lines have been used to evaluate their properties, and the
Caco-2 cell line is one of the most suitable models for this
purpose, particularly for ETEC strains carrying the CFA/I
and CFA/II (CS2) adhesions (Darfeuille-Michaud et al.,
1990; Viboud et al., 1996).
The prevalence of CFs amongst clinical ETEC isolates
differs considerably depending on the geographic region,
but several epidemiological studies conducted in different
countries have indicated that 23–94% of human ETEC
isolates express either CFA/I, CFA/II or CFA/IV (Wolf,
1997; Kaper et al., 2004). ETEC strains are also important
pathogens in Sa˜o Paulo, Brazil, and are responsible for
7–20% of cases of infantile diarrhea (Reis et al., 1982; Gomes
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et al., 1991). Moreover, different studies have shown that
CFs occur in 29–43% of the isolated strains, and CFA/I or
CFA/II accounted for the most prevalent CFs identified
(Reis et al., 1982; Guth et al., 1994; Nunes, 2000).
Extensive studies support the concept that breast-feeding is
effective in protecting infants against infectious diseases, such
as diarrhea (Kovar et al., 1984; Blake et al., 1993). Several
factors in human milk, including antibodies and nonspecific
factors with antibacterial and antiviral activity, may be im-
portant in conferring this protective role (Taylor & Dimmock,
1985; Mazanec et al., 1993). Immunoglobulin A (IgA)
accounts for 70% of total body immunoglobulin production
and has been found to be the main immunoglobulin in
human milk, accounting for more than 90% of the immuno-
globulins (Xanthou, 1998; Macpherson & Uhr, 2004). Human
milk contains antibodies directed against a variety of patho-
gens, to which the mother has been exposed during her
lifetime, that will protect the offspring against the prevalent
pathogens in the environment (Kolb, 2001). The main func-
tion of IgA is to bind and block the adherence of microbial
pathogens to the intestinal epithelial surface and neutralize
their toxins (Cravioto et al., 1991). Several studies have already
demonstrated that secretory IgA antibodies of colostrum
obtained from Brazilian women strongly inhibited the in vitro
adhesion of enteropathogenic and Shiga toxin-producing E.
coli to human epithelial cells (Carbonare et al., 1997; Palmeira
et al., 2005). Moreover, Nathavitharana et al. (1995) reported
the presence of specific secretory IgAs reactive to CFA/I in the
milk and saliva of Sri Lankan and Asian women.
The importance of CFs in ETEC pathogenesis is well
known, and thus it can be proposed that the presence of
specific anti-CF IgA in human colostrum will block the
adhesion capacity of ETEC strains. Therefore, the aim of this
study was to analyze the reactivity of IgA from different
samples of human colostrum against CFA/I and CFA/II, the
major CFs identified in our community. The ability of
colostrum in preventing ETEC adhesion to Caco-2 cells was
also evaluated for the first time.
Materials and methods
Bacterial strains and culture conditions
The prototype ETEC strains used in this study were TR69/1
(CFA/I1, O63:H, LT/ST), isolated from a child with
diarrhea in Sa˜o Paulo (Reis et al., 1982), TR69/1-P, a
plasmidless mutant lacking CFA/I (CFA/I), 258903 (CFA/
I1, O128:H, ST/LT), a gift from Dr A. M. Svennerholm
(Go¨teborg University, Sweden), PB176 (CFA/II1 with CS1/
CS3, O6:H16, LT/ST) (Evans & Evans, 1978) and 58R957
(CFA/II1 with CS2, O6:H16, LT/ST), kindly provided by Dr
G. Viboud (Stony Brook University, New York). In all assays,
the strains were inoculated into tryptic soy broth (TSB),
grown for 16 h and plated on to casamino acids–yeast
extract agar (CFA) incubated for 18 h. The fimbrial extracts
were prepared as described previously (Levine et al., 1984).
Human colostrum
Colostrum samples were collected from 32 clinically healthy
18–35-year-old women, living in slums, at the Hospital of
the University of Sa˜o Paulo, between 48 and 72 h after the
delivery of normal term babies. Appropriate informed
consent and institutional ethics committee approval were
obtained, and all guidelines for human experimentation
were followed in this study. The women were not receiving
any medication, were negative for HIV, hepatitis B and
syphilis, and did not present severe infectious diseases
during either pregnancy or the delivery period. Samples
were delipidated by centrifugation at 4 1C, and the colos-
trum pool was prepared with equal volumes of liquid phase
from each sample and stored at  20 1C until use.
Colostrum pool absorptions
Different aliquots of the colostrum pool were absorbed with
ETEC strains expressing CFA/I1 (258903), CFA/II1–CS21
(58R957) or CFA/I plasmidless mutant (CFA/I, TR69/1-P)
by adding the specific ETEC culture to the colostrum as
described by Carbonare et al. (1997). Another aliquot of
colostrum pool was also totally IgA depleted. Briefly, the
colostrum pool was decaseinated by acidification with acetic
acid, and then applied to an antihuman IgA CNBr-activated
Sepharose (Sigma, St Louis, MO) column to obtain an IgA-
depleted fraction and an IgA-enriched preparation (eluate),
as described previously (Fernandes et al., 2001). The
absorbed supernatants and IgA-depleted and IgA-enriched
preparations were maintained at  20 1C.
Adhesion to Caco-2 cells
Caco-2 cells, a human cell line derived from a carcinoma of
the colon that exhibits structural and functional differentia-
tion patterns characteristic of mature enterocytes in post-
confluent cultures, were grown for 10 days in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma) containing
4.5 g L1 glucose, 1% MEM nonessential amino acids,
25mM HEPES, 2mM L-glutamine, 0.5% of 50mgmL1
gentamycin (all from Sigma) and 10% fetal bovine serum
(Cultilab, Campinas, Brazil) in chamber slides for tissue
culture (Nunc Inc., Glostrup, Denmark). Suspensions of
CFA/I1 and CFA/II1 (CS2) containing 108 CFUmL1 were
added to the medium of the tissue culture supplemented
with 2% D-mannose, and the mixture was incubated at 37 1C
for 3 h. After four washes with phosphate-buffered saline
(PBS), cells were fixed with methanol and stained with 20%
Giemsa stain (adherence positive control). Individual colo-
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strum samples and the original or absorbed colostrum pools
were examined in inhibition assays, as described by Silva &
Giampaglia (1992) with some modifications. Colostrum
diluted 1 : 50, 1 : 100 and 1 : 200 was added to the mixture
of bacterial suspension and tissue culture, and the test was
performed as mentioned above. At least 400 cells were
observed in each preparation under a light microscope
(400 or 1000 magnification). The amount of adhesion
was determined by calculating the percentage of cells with
six or more adhering bacteria on the cell surface. The
inhibitory effect of colostrum was calculated as the differ-
ence between the percentage of bacterial adhesion in control
wells without colostrum and that in wells containing the
colostrum samples100 (%). The values represented the
mean of at least three experiments for individual colostrum
samples and the mean of seven experiments for whole
pooled colostrum.
Detection of ETEC antibodies
Anti-ETEC CFA/I1, anti-ETEC CFA/I and anti-ETEC
CFA/II1 (CS1/CS3 and CS2) IgA titers were determined by
enzyme-linked immunosorbent assay (ELISA), as described
by Carbonare et al. (1995). Briefly, ELISA plates (Costar)
were coated with whole cell suspension adjusted to an optical
density (OD) of 0.7 at l= 540 nm. Individual colostrum
samples and the original or absorbed colostrum pool were
evaluated in serial dilutions, and antihuman IgA peroxidase
conjugate (Sigma) was used for the detection of IgA.
Fimbrial extracts were diluted to a concentration of 1mg
mL1 and loaded on to 15% sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) gels and stained with
Coomassie Brilliant Blue G or, for immunoblotting assays,
were blotted on to nitrocellulose membranes (Towbin et al.,
1979). The strips were incubated overnight with appropriate
dilutions of colostrum, and antihuman IgA peroxidase
conjugate, diluted 1 : 4000, was used in the reaction (Sigma).
The reaction was developed with the substrate in 3,30-
diaminobenzidine (DAB) (Sigma) (Carbonare et al., 2003).
Results
Human colostrum inhibits ETEC adhesion to
Caco-2 cells
The adhesion of ETEC CFA/I1 and ETEC CFA/II1 (CS21)
to Caco-2 cells was strongly inhibited by the colostrum pool
and all individual samples. Figure 1 shows the adhesion
pattern of the ETEC CFA/I1 strain (258903), and Table 1
summarizes all the results of the adhesion assays. IgA-
depleted colostrum lost its inhibitory effect, whereas the
IgA-enriched preparation maintained its inhibitory activity.
The pooled colostrum lost its inhibitory activity on adhe-
sion of the homologous strain after absorption with ETEC
CFA/I1 and CFA/II1 (CS2) strains, and presented partial
loss of its inhibitory activity when the heterologous strain
was assayed (Table 1).
IgA antibodies from colostrum samples
The fimbrial extracts analyzed by SDS-PAGE stained with
Coomassie Brilliant Blue G demonstrated a typical CFA/I
Fig. 1. Micrograph showing the adhesion of enterotoxigenic Escheri-
chia coli (ETEC) colonization factor antigen I-positive (CFA/I1) strain
258903 (O128:H, ST/LT) to the Caco-2 cell line. (a) Control adhesion
without colostrum; (b) adhesion inhibition in the presence of pooled
human colostrum; (c) absence of adhesion inhibition in the presence of
immunoglobulin A (IgA)-depleted pooled human colostrum. Cells and
bacteria were stained with 20% Giemsa stain and were observed at
1000 magnification.
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band of 16 kDa (Fig. 2, lane A), which was absent in lane B
(the fimbrial extract of the plasmidless mutant strain lacking
CFA/I), and typical bands of CS1, CS3 and CS2 of CFA/II1
with molecular weights of 18 and 16 kDa (lane C) and
15.3 kDa (lane D), respectively. Immunoblotting assays
using anti-IgA immunoglobulins detected several proteins,
including CFA/I and CS1, CS3 and CS2 of CFA/II, in pooled
colostrum (Fig. 3a) as well as in the IgA-enriched prepara-
tion (Fig. 3c). No recognition of these CFAs was observed
when IgA-depleted colostrum was assayed (Fig. 3b). A
differential pattern of recognition to CFA/I and CFA/II was
observed amongst the individual colostrum samples tested
(Fig. 4). Of 17 individual colostrum samples tested, four
presented IgA antibodies against CFA/I, CS1/CS3 of CFA/II
and CS2 of CFA/II (Fig. 4a), 12 recognized just CFA/II (Fig.
4b) and, in five samples, no IgA antibodies against these
CFAs were identified (Fig. 4c).
Titers of IgA antibodies raised to ETEC proteins
in colostrum
ETEC antibody levels in human colostrum are summarized
in Fig. 5. ELISA performed with 11 individual colostrum
samples showed variable anti-ETEC CFA/I (Fig. 5a) and
anti-ETEC CFA/II (Fig. 5b) IgA titers. The colostrum pool
absorbed with either ETEC CFA/I1 or ETEC CFA/II1
demonstrated a large decrease in anti-CF IgA titers. Absorp-
tion with the CFA/I plasmidless mutant (CFA/I) also
resulted in a decrease in IgA titers reactive to CFA/I1.
Discussion
Breast-feeding is undoubtedly associated with protection
against a great variety of neonatal infections and, consider-
ing that diarrhea is still of concern with regard to child
mortality, especially in developing countries, the role of
human milk in protecting infants against diarrhea has been
investigated by several authors (Martins Filho et al., 1980;
Silva & Giampaglia, 1992; Carneiro-Sampaio et al., 1996;
Fernandes et al., 2001). Breast-fed infants are more resistant
to infectious diseases, especially those of the gastrointestinal
tract, when compared with bottle-fed children (Martins
Filho et al., 1980).
Enterotoxigenic Escherichia coli is a major cause of acute
diarrhea and is responsible for a high rate of infantile
mortality in developing countries, including Brazil (Guth
et al., 1994; Nunes, 2000).
In this study, we showed that a human colostrum pool, as
well as individual colostrum samples, was able to strongly
inhibit the in vitro adhesion of CFA/I- and CFA/II-produ-
cing ETEC strains to the Caco-2 cell line. It was also
observed that the colostrum pool and several individual
Table 1. Inhibition of enterotoxigenic Escherichia coli (ETEC) adhesion
to Caco-2 cells by human colostrum
Material‰
Adhesion inhibition (%)
CFA/I1
w
CFA/II1
(CS2)z
Whole pooled colostrum 91.4 92.3
IgA-depleted pooled colostrum 19.3 3.8
Purified IgA from pooled colostrum 91.6 94.4
Pooled colostrum absorbed with
CFA/II1 (CS2) strain
47.0 3.3
Pooled colostrum absorbed with
CFA/I1 strain
3.1 43.0
Pooled colostrum absorbed with CFA/I
plasmidless mutant
90.6 50.8
Sample 4 97.7 95.1
Sample 5 93.9 79.5
Sample 15 98.0 97.4
Sample 23 89.9 43.6
CFA/I, colonization factor antigen I; CFA/II, colonization factor antigen II;
IgA, immunoglobulin A; LT, heat-labile toxin; ST, heat-stable toxin.
Difference between the percentage of adhesion in control (without
colostrum) after observation of 400 cells and the percentage of bacterial
adhesion in wells containing the colostrum samples100(%). Values
represent the mean of at least three experiments with each individual
colostrum sample and the mean of seven experiments with whole
pooled colostrum.
wCFA/I1 strain: 258903 (O128:H, ST/LT).
zCFA/II1 (CS2) strain: 58R957 (O6:H16, LT/ST).
‰Colostrum samples were diluted 1 : 50.
Fig. 2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) on acrylamide 15% gel of fimbrial extracts of prototype enter-
otoxigenic Escherichia coli (ETEC) strains. Lanes: A, CFA/I1; B, CFA/I; C,
CS1 and CS3 of CFA/II1; D, CS2 of CFA/II1. The arrows indicate the band
of CFA/I in lane A, CS1 and CS3 in lane C and CS2 in lane D. CFA/I,
colonization factor antigen I; CFA/II, colonization factor antigen II.
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samples contained IgA antibodies that were reactive to these
ETEC CFs, thus suggesting that IgA may be responsible for
the presently identified inhibitory effect of colostrum.
Indeed, this seems to be the case, as IgA-depleted colostrum
lost almost 100% of its inhibitory capacity, whereas
IgA-enriched eluate maintained this ability.
The inhibitory activity of human colostrum and breast
milk to the adherence of other categories of diarrheagenic
Escherichia coli to HEp-2 cells has been reported previously
(Cravioto et al., 1991; Carbonare et al., 1995; Wold &
Adlerberth, 2000; Fernandes et al., 2001). Several constitu-
ents capable of binding to pathogenic bacteria and of inhi-
biting adhesion are present in human milk. In one study, it
was found that fucosylated saccharides prevented the adhe-
sion of enteropathogenic E. coli (EPEC) (Cravioto et al.,
1991), whereas others stressed the important role of IgA
antibodies in blocking this bacterial adherence (Silva &
Giampaglia, 1992; Caˆmara et al., 1994; Carbonare et al., 1997).
In relation to ETEC, the only two studies described so far
have reported the role of lactoferrin and the secretory
component, as well as colostrum and human milk oligosac-
charides, in blocking ETEC CFA/I and CFA/II hemaggluti-
nation (Giugliano et al., 1995; Martin-Sosa et al., 2002).
Thus, the important role of IgA antibodies in preventing
CF-mediated ETEC adherence to cultured cells has not been
reported previously.
We also investigated the presence of specific antibodies
reactive to CFA/I and CFA/II by absorbing aliquots of the
human colostrum pool with each one of these strains.
Adherence and ELISA assays performed with the colostrum
pool absorbed with ETEC CFA/I1 or CFA/II1 (CS2) strains
demonstrated that its inhibitory activity was lost, and that
the antibody titers were drastically reduced when the
homologous strain was tested. The inhibitory capacity also
decreased when the heterologous strain was assayed, prob-
ably as a result of the removal of polyclonal antibodies
contained in the human colostrum pool that could react
with common epitopes amongst these bacteria to different
degrees. Absorption with the CFA/I plasmidless mutant
(CFA/I) revealed that the colostrum pool maintained its
inhibitory activity, indicating the great importance of anti-
CFA/I antibodies in the adhesion inhibitory phenomenon
identified in this study.
The variable titers of IgA reactive to ETEC CFA/I and
CFA/II observed in individual colostrum samples by ELISA
were also confirmed through immunoblotting assays, in
which different degrees of CFA/I and CFA/II (CS1/CS3 or
CS2) antigen recognition were identified. Despite this
Fig. 3. Immunoblotting analysis with pooled
colostrum (a), immunoglobulin A (IgA)-depleted
colostrum (b) and IgA-enriched eluate (c) and
extracts of enterotoxigenic Escherichia coli
(ETEC) colonization factors. Lanes: 1, CFA/I1
extract; 2, CFA/I extract; 3, CFA/II1 (CS1/CS3)
extract; 4, CFA/II1 (CS2) extract. All materials
were assayed at 1 : 50 dilution. Peroxidase-con-
jugated antihuman IgA was used at 1 : 4000
dilution. The arrows show CFA/I, CS1/CS3 and
CS2 from CFA/II. CFA/I, colonization factor anti-
gen I; CFA/II, colonization factor antigen II.
Fig. 4. Immunoblotting analysis with individual
colostrum samples and extracts of enterotoxi-
genic Escherichia coli (ETEC) colonization factors:
a, colostrum sample 15; b, colostrum sample 5;
c, colostrum sample 23. Lanes: 1, CFA/I1 extract;
2, CFA/I extract; 3, CFA/II1 (CS1/CS3) extract; 4,
CFA/II1 (CS2) extract. All materials were assayed
at 1 : 50 dilution. Peroxidase-conjugated antihu-
man immunoglobulin A (IgA) was used at
1 : 4000 dilution. The arrows show CFA/I, CS1/
CS3 and CS2 from CFA/II. CFA/I, colonization
factor antigen I; CFA/II, colonization factor anti-
gen II.
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variability, all colostrum samples inhibited ETEC adhesion
to Caco-2 cells, indicating that even low anti-ETEC IgA
levels detected by ELISA were sufficient to promote the
inhibition of bacterial adhesion. Moreover, in the individual
samples which did not present detectable anti-CF IgA
antibodies by these techniques, the role of other colostrum
components, such as oligosaccharides and lactoferrin, in
blocking ETEC adhesion could be suggested.
It was interesting to observe that a larger number of
samples recognized CFA/II (CS1/CS3) more strongly than
CFA/I by immunoblotting assays. Taking into consideration
previous epidemiological studies conducted in Sa˜o Paulo
(Reis et al., 1982; Guth et al., 1994; Nunes, 2000), which
showed that CFA/I occurred more frequently than CFA/II,
these findings could suggest that CFA/II is a stronger
immunogen than CFA/I, rather than reflecting a larger
environmental exposure to ETEC CFA/II strains in our
population.
Quadri et al. (2003) studied the importance of the
mucosal immune response when 158 children were vacci-
nated with oral formalin-inactivated ETEC vaccine contain-
ing six CFs (CFA/I, CS1, CS2, CS3, CS4 and CS5) and
recombinant cholera toxin B subunit. They verified that the
children presented significant increases of CF-specific anti-
body-secreting cells of the IgA isotype after the intake of the
first dose of the vaccine, and these results confirmed the
importance of the mucosal immune response in preventing
ETEC diarrhea. Moreover, Freedman et al. (Freedman et al.,
1998) verified that CFA/I is a potent immunogen when
compared with LT toxin and purified lipopolysaccharide in
cattle immunization. Anti-CFA/I titers were 32 times higher
than those of the other antigens tested. In addition, CFA/I
antibodies alone were sufficient for protection when 25
volunteers were orally challenged with ETEC CFA/I after
receiving IgG concentrate derived from immunized cows.
In conclusion, this study showed, for the first time, that
colostrum obtained from Brazilian mothers living in low
socio-economic conditions was able to inhibit ETEC CFA/I
and CFA/II adhesion to Caco-2 cells, at variable levels, and
this ability was a result of the IgA antibodies reactive to these
antigens. As bacterial adhesion is the initial mechanism of
ETEC infection, breast-feeding could protect the infant
against diarrhea caused by this agent, confirming once again
the great importance of this natural practice in preserving
the good health of infants.
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